Delivery Order SPE2DB22D3009-SPE2DB25FBB73
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of M-M-R II vaccine vials, with a ceiling value of $4,185.90. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $2,351.28 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for M-M-R II vaccine vials, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, without a set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor vehicle designed to provide comprehensive pharmaceutical and medical supply support to military...
- This is a $26,643.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of July 19, 2024 and does not utilize a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $12,185.58. The contract was competitively awarded with no set-aside designation and employs firm fixed price pricing. The delivery order has an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,225.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- This is a $1,107.78 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of M-M-R II vaccine vials and has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a $3,479.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of M-M-R II vaccine vials, with a performance period extending through April 9, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,933.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. The delivery order represents a small-value transaction typical of routine pharmaceutical...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBB73Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,711.00 to AmerisourceBergen Drug Corp for MMR II vaccine vials, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has been selected to supply these immunological products to support military and federal healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices, to support Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems on a global basis. The MMR II vaccine order represents a routine fulfillment under this expansive vehicle designed to provide flexible, on-demand pharmaceutical support to military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 7/23/25 |